Maddocks, K. J., Ruppert, A. S., Lozanski, G., Heerema, N. A., Zhao, W., Abruzzo, L., . . . Woyach, J. A. (2015). Etiology of Ibrutinib Discontinuation and Outcomes in Chronic Lymphocytic Leukemia Patients. JAMA Oncol.
Citación estilo ChicagoMaddocks, Kami J., et al. "Etiology of Ibrutinib Discontinuation and Outcomes in Chronic Lymphocytic Leukemia Patients." JAMA Oncol 2015.
Cita MLAMaddocks, Kami J., et al. "Etiology of Ibrutinib Discontinuation and Outcomes in Chronic Lymphocytic Leukemia Patients." JAMA Oncol 2015.
Precaución: Estas citas no son 100% exactas.